Ost-müük Better Therapeutics, Inc. - BTTX CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.0562 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 0.6683 |
Avatud* | 0.6671 |
Aastane muutus* | -67.3% |
Päeva ulatus* | 0.6486 - 0.7027 |
52 nädala ulatus | 0.59-2.80 |
Keskmine maht (10 päeva) | 135.87K |
Keskmine maht (3 kuud) | 2.90M |
Turukapitalisatsioon | 21.89M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 31.73M |
Tulu | N/A |
EPS | -1.67 |
Dividendid (% kasumist) | N/A |
Beeta | -100.00K |
Järgmine tuluaruande kuupäev | Aug 9, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 0.6830 | 0.0159 | 2.38% | 0.6671 | 0.7263 | 0.6480 |
May 25, 2023 | 0.6683 | -0.0257 | -3.70% | 0.6940 | 0.7422 | 0.6483 |
May 24, 2023 | 0.7168 | -0.0290 | -3.89% | 0.7458 | 0.7459 | 0.6924 |
May 23, 2023 | 0.7507 | 0.0054 | 0.72% | 0.7453 | 0.7651 | 0.7453 |
May 22, 2023 | 0.7555 | 0.0201 | 2.73% | 0.7354 | 0.7942 | 0.7354 |
May 19, 2023 | 0.7564 | 0.0013 | 0.17% | 0.7551 | 0.7747 | 0.7540 |
May 18, 2023 | 0.7554 | -0.0015 | -0.20% | 0.7569 | 0.7845 | 0.7356 |
May 17, 2023 | 0.7582 | 0.0126 | 1.69% | 0.7456 | 0.7797 | 0.7456 |
May 16, 2023 | 0.7620 | -0.0388 | -4.85% | 0.8008 | 0.8037 | 0.7260 |
May 15, 2023 | 0.7457 | -0.0580 | -7.22% | 0.8037 | 0.8136 | 0.7359 |
May 12, 2023 | 0.7470 | 0.0310 | 4.33% | 0.7160 | 0.7749 | 0.7159 |
May 11, 2023 | 0.7555 | -0.0823 | -9.82% | 0.8378 | 0.8571 | 0.7257 |
May 10, 2023 | 0.8349 | 0.0215 | 2.64% | 0.8134 | 0.8716 | 0.7544 |
May 9, 2023 | 0.8039 | 0.0391 | 5.11% | 0.7648 | 0.8137 | 0.7262 |
May 8, 2023 | 0.7746 | -0.1165 | -13.07% | 0.8911 | 0.8911 | 0.6907 |
May 5, 2023 | 0.9005 | 0.0042 | 0.47% | 0.8963 | 0.9298 | 0.8905 |
May 4, 2023 | 0.9297 | -0.1353 | -12.70% | 1.0650 | 1.0653 | 0.8708 |
May 3, 2023 | 1.0750 | 0.0017 | 0.16% | 1.0733 | 1.1041 | 1.0635 |
May 2, 2023 | 1.0944 | 0.0095 | 0.88% | 1.0849 | 1.1233 | 1.0652 |
May 1, 2023 | 1.0943 | -0.0281 | -2.50% | 1.1224 | 1.1332 | 1.0741 |
Better Therapeutics, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Wednesday, August 9, 2023 | ||
Kellaaeg (UTC) (UTC) 20:00 | Riik US
| Sündmus Q2 2023 Better Therapeutics Inc Earnings Release Q2 2023 Better Therapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
Kellaaeg (UTC) (UTC) 21:00 | Riik US
| Sündmus Q3 2023 Better Therapeutics Inc Earnings Release Q3 2023 Better Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | |
---|---|---|---|
Kogutulu | 0 | 0 | 0 |
Kogu tegevuskulu | 38.262 | 40.303 | 0.00169 |
Other Operating Expenses, Total | 0.00169 | ||
Tulud majandustegevusest | -38.262 | -40.303 | -0.00169 |
Netotulu enne makse | -39.753 | -40.488 | -0.00169 |
Netotulu pärast makse | -39.76 | -40.335 | -0.00169 |
Netotulu enne erikulusid | -39.76 | -40.335 | -0.00169 |
Netotulu | -39.76 | -40.335 | -0.00169 |
Arvestatav tulu, v a erikulud | -39.76 | -40.335 | -0.00169 |
Arvestatav tulu, koos erikuludega | -39.76 | -40.335 | -0.00169 |
Jaotamisele kuuluv netotulu | -39.76 | -40.335 | -0.00169 |
Keskmine jaotamisele kuuluv aktsia kohta | 23.5578 | 23.6027 | 7.5575 |
Jaotatav EPS, v a erakorralised kulud | -1.68776 | -1.70891 | -0.00022 |
Dividends per Share - Common Stock Primary Issue | 0 | ||
Jaotamisele kuuluv normaal-EPS | -1.68776 | -1.4406 | -0.00022 |
Müük/Üldine/admin kulud, kokku | 21.822 | 11.124 | |
Uuringud ja arendus | 16.44 | 19.436 | |
Ootamatud kulutused (tulu) | 0 | 9.743 | |
Intressitulud (kulu), muud tulud, neto | -1.491 | -0.185 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Kogu tegevuskulu | 8.925 | 8.322 | 10.996 | 9.599 | 9.345 |
Other Operating Expenses, Total | |||||
Tulud majandustegevusest | -8.925 | -8.322 | -10.996 | -9.599 | -9.345 |
Intressitulud (kulu), muud tulud, neto | -0.431 | -0.439 | -0.406 | -0.329 | -0.317 |
Netotulu enne makse | -9.356 | -8.761 | -11.402 | -9.928 | -9.662 |
Netotulu pärast makse | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
Netotulu enne erikulusid | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
Netotulu | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
Arvestatav tulu, v a erikulud | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
Arvestatav tulu, koos erikuludega | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
Jaotamisele kuuluv netotulu | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
Keskmine jaotamisele kuuluv aktsia kohta | 23.8266 | 23.6315 | 23.6931 | 23.593 | 23.4132 |
Jaotatav EPS, v a erakorralised kulud | -0.39271 | -0.3709 | -0.48136 | -0.4208 | -0.41267 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.39271 | -0.3709 | -0.48136 | -0.4208 | -0.41267 |
Müük/Üldine/admin kulud, kokku | 5.536 | 5.273 | 5.519 | 5.358 | 5.672 |
Uuringud ja arendus | 3.389 | 3.049 | 5.477 | 4.241 | 3.673 |
Ootamatud kulutused (tulu) | 0 | 0 | 0 | 0 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | |
---|---|---|---|
Käibevarad kokku | 18.446 | 45.251 | 0.08666 |
Raha ja lühiajalised investeeringud | 15.74 | 40.566 | 0.02476 |
Cash | 0.02476 | ||
Other Current Assets, Total | 0.21 | 0.276 | 0.06189 |
Total Assets | 22.943 | 50.958 | 0.08666 |
Total Current Liabilities | 13.494 | 4.733 | 0.06334 |
Accrued Expenses | 5.927 | 3.21 | 0.00145 |
Notes Payable/Short Term Debt | 0 | 0 | 0.06189 |
Total Liabilities | 23.842 | 14.238 | 0.06334 |
Total Long Term Debt | 10.348 | 9.505 | 0 |
Total Equity | -0.899 | 36.72 | 0.02331 |
Common Stock | 0.002 | 0.002 | 0.00014 |
Additional Paid-In Capital | 110.602 | 108.461 | 0.02486 |
Retained Earnings (Accumulated Deficit) | -111.503 | -71.743 | -0.00169 |
Total Liabilities & Shareholders’ Equity | 22.943 | 50.958 | 0.08666 |
Total Common Shares Outstanding | 23.851 | 23.6027 | 7.5575 |
Raha ja ekvivalendid | 15.74 | 40.566 | |
Prepaid Expenses | 2.496 | 4.409 | |
Property/Plant/Equipment, Total - Net | 0.121 | 0.082 | |
Intangibles, Net | 3.888 | 5.077 | |
Other Long Term Assets, Total | 0.488 | 0.548 | |
Accounts Payable | 3.035 | 1.523 | |
Long Term Debt | 10.348 | 9.505 | |
Property/Plant/Equipment, Total - Gross | 0.178 | ||
Accumulated Depreciation, Total | -0.057 | ||
Current Port. of LT Debt/Capital Leases | 4.532 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 8.442 | 18.446 | 23.49 | 32.137 | 35.179 |
Raha ja lühiajalised investeeringud | 6.068 | 15.74 | 22.305 | 29.685 | 31.673 |
Cash | |||||
Prepaid Expenses | 1.968 | 2.496 | 1.123 | 2.38 | 3.242 |
Total Assets | 12.808 | 22.943 | 28.221 | 37.103 | 40.291 |
Long Term Investments | |||||
Other Long Term Assets, Total | 0.483 | 0.488 | 0.488 | 0.487 | 0.488 |
Total Current Liabilities | 13.64 | 13.494 | 9.312 | 6.141 | 3.567 |
Accrued Expenses | 5.588 | 5.927 | 4.928 | 3.27 | 2.528 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 22.641 | 23.842 | 20.969 | 19.049 | 12.866 |
Total Long Term Debt | 9.001 | 10.348 | 11.657 | 12.908 | 9.299 |
Other Liabilities, Total | |||||
Total Equity | -9.833 | -0.899 | 7.252 | 18.054 | 27.425 |
Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 111.025 | 110.602 | 109.988 | 109.385 | 108.828 |
Retained Earnings (Accumulated Deficit) | -120.86 | -111.503 | -102.738 | -91.333 | -81.405 |
Total Liabilities & Shareholders’ Equity | 12.808 | 22.943 | 28.221 | 37.103 | 40.291 |
Total Common Shares Outstanding | 23.8523 | 23.851 | 23.7441 | 23.733 | 23.6086 |
Payable/Accrued | |||||
Raha ja ekvivalendid | 6.068 | 15.74 | 22.305 | 29.685 | 31.673 |
Other Current Assets, Total | 0.406 | 0.21 | 0.062 | 0.072 | 0.264 |
Property/Plant/Equipment, Total - Net | 0.131 | 0.121 | 0.122 | 0.115 | 0.098 |
Intangibles, Net | 3.752 | 3.888 | 4.121 | 4.364 | 4.526 |
Accounts Payable | 2.513 | 3.035 | 1.255 | 1.088 | 0.735 |
Long Term Debt | 9.001 | 10.348 | 11.657 | 12.908 | 9.299 |
Current Port. of LT Debt/Capital Leases | 5.539 | 4.532 | 3.129 | 1.783 | 0.304 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | |
---|---|---|---|
Netotulu/algväärtus | -39.76 | -40.335 | -0.00169 |
Raha majandustegevusest | -28.93 | -30.818 | -0.00024 |
Muutused tööjõus | 6.268 | -2.339 | 0.00145 |
Rahavood investeeringutelt | 5.284 | 72.332 | 0.025 |
Rahavoogudesse investeerimine | 0 | 62.331 | -0.06189 |
Aktsiate emiteerimine (tagasiost), neto | 0.284 | 0.001 | 0.025 |
Laenu väljastamine (kustutamine), neto | 5 | 10 | 0.06189 |
Rahaline kogumuutus | -24.826 | 40.443 | 0.02476 |
Raha majandustegevusest | 2.729 | 1.619 | |
Deferred Taxes | 0 | -0.152 | |
Mittelikviidsed varad | 1.833 | 10.389 | |
Makstud intressid | 1.325 | 0.085 | |
Tulu investeeringutelt | -1.18 | -1.071 | |
Kapitalikulutused | -1.18 | -1.071 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.357 | -39.76 | -30.995 | -19.59 | -9.662 |
Cash From Operating Activities | -8.716 | -28.93 | -22.593 | -15.57 | -8.855 |
Non-Cash Items | 0.41 | 1.833 | 1.384 | 0.787 | 0.375 |
Changes in Working Capital | -0.524 | 6.268 | 5.01 | 1.919 | -0.231 |
Cash From Investing Activities | -0.521 | -1.18 | -0.82 | -0.457 | -0.039 |
Other Investing Cash Flow Items, Total | |||||
Cash From Financing Activities | -0.435 | 5.284 | 5.152 | 5.146 | 0.001 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0 | 0.284 | 0.152 | 0.146 | 0.001 |
Issuance (Retirement) of Debt, Net | -0.435 | 5 | 5 | 5 | |
Net Change in Cash | -9.672 | -24.826 | -18.261 | -10.881 | -8.893 |
Cash From Operating Activities | 0.755 | 2.729 | 2.008 | 1.314 | 0.663 |
Deferred Taxes | 0 | 0 | 0 | 0 | |
Cash Interest Paid | 0.495 | 1.325 | 0.87 | 0.462 | 0.219 |
Capital Expenditures | -0.521 | -1.18 | -0.82 | -0.457 | -0.039 |
Cash Taxes Paid | 0 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Perry (David P) | Individual Investor | 53.1606 | 16868581 | 6404566 | 2023-04-12 | LOW |
Georgianna Maule-Ffinch 2015 Trust | Individual Investor | 11.4598 | 3636364 | 3636364 | 2023-04-10 | |
Appelbaum (Kevin J) | Individual Investor | 7.5847 | 2406719 | -6250 | 2023-04-10 | LOW |
Mountain Crest Capital LLC | Corporation | 4.375 | 1388250 | 0 | 2023-04-10 | LOW |
Farallon Capital Management, L.L.C. | Hedge Fund | 2.203 | 699042 | -114514 | 2023-03-31 | MED |
Armanino (Andrew J) | Individual Investor | 1.4739 | 467692 | 303030 | 2023-04-10 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3818 | 438479 | 3700 | 2023-03-31 | LOW |
Parker (Geoffrey M) | Individual Investor | 1.2491 | 396363 | 303030 | 2023-04-10 | LOW |
Maule-Ffinch (Georgianna) | Individual Investor | 0.9238 | 293150 | 0 | 2023-04-10 | LOW |
Karbe (Frank L) | Individual Investor | 0.9216 | 292424 | 242424 | 2023-04-10 | MED |
Berman Mark A | Individual Investor | 0.7309 | 231939 | 0 | 2023-04-10 | LOW |
Carmona (Richard H. M.D.) | Individual Investor | 0.4841 | 153619 | 0 | 2023-04-10 | LOW |
Wynholds (Kristin) | Individual Investor | 0.3114 | 98819 | 0 | 2023-04-10 | LOW |
Heinen (Mark) | Individual Investor | 0.2773 | 88004 | 1 | 2023-04-10 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2523 | 80054 | 798 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.18 | 57109 | 0 | 2023-03-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.1497 | 47516 | -6473 | 2023-03-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1424 | 45200 | 0 | 2023-03-31 | LOW |
Zamirowski (Justin) | Individual Investor | 0.1163 | 36913 | 36913 | 2022-05-27 | |
Millennium Management LLC | Hedge Fund | 0.0837 | 26556 | 14932 | 2023-03-31 | HIGH |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group530K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$46M+
Igakuine investeerimise maht
$31M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Better Therapeutics, Inc. Company profile
Ettevõttest Better Therapeutics, Inc.
Better Therapeutics, Inc, varem Mountain Crest Acquisition Corp II, tegeleb retseptiravimite digitaalse raviplatvormi pakkumisega kardiometaboolsete haiguste raviks. Ettevõte loob ravimeetodid haiguse progresseerumise peatamiseks, elukvaliteedi parandamiseks ja kliiniliste otsuste teavitamiseks. Ettevõte loob retsepti alusel väljastatavaid digitaalseid ravimeid, mis pakuvad uut tüüpi käitumisteraapiat ja loovad tagasisidemehhanisme, kasutades kaugjälgitud ja patsiendi poolt genereeritud andmeid. Ettevõtte kliiniline arendustegevus hõlmab BT-001, BT-002, BT-003, BT-004 ja BT-005. BT-001't hinnatakse praegu otsustava tähtsusega uuringus, mida kasutatakse arsti järelevalve all kontrollimatu 2. tüüpi diabeedi all kannatavatele inimestele ettenähtud ravina. Ettevõte arendab toitumisalast kognitiivset käitumisteraapiat (Nutritional Cognitive Behavioral Therapy, CBT), mis on uudne käitumisteraapia vorm, mida arendatakse 2. tüüpi diabeedi ja teiste kardiometaboolsete haiguste patsientide raviks.
Industry: | Biotechnology & Medical Research (NEC) |
548 Market St. #49404
SAN FRANCISCO
CALIFORNIA 94101
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 530,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com